These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19719397)

  • 1. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.
    Major EO
    Annu Rev Med; 2010; 61():35-47. PubMed ID: 19719397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The link between VLA-4 and JC virus reactivation.
    Monaco MC; Major EO
    Expert Rev Clin Immunol; 2012 Jan; 8(1):63-72. PubMed ID: 22149341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
    Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
    J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
    Sabath BF; Major EO
    J Infect Dis; 2002 Dec; 186 Suppl 2():S180-6. PubMed ID: 12424695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
    Tan CS; Koralnik IJ
    Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of plasma exchange on serum anti-JC virus antibodies.
    Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
    Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human JC polyomavirus (JCPyV): virological background and clinical implications.
    Hirsch HH; Kardas P; Kranz D; Leboeuf C
    APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.
    Tornatore C; Berger JR; Houff SA; Curfman B; Meyers K; Winfield D; Major EO
    Ann Neurol; 1992 Apr; 31(4):454-62. PubMed ID: 1316734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of progressive multifocal leukoencephalopathy and natalizumab.
    Aksamit AJ
    Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History and current concepts in the pathogenesis of PML.
    Major EO
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S3-7. PubMed ID: 22123932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review.
    Sharma K; Tolaymat S; Yu H; Elkhooly M; Jaiswal S; Jena A; Kakara M; Sriwastava S
    J Neurol Sci; 2022 Dec; 443():120459. PubMed ID: 36283150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection.
    Martin-Blondel G; Bauer J; Cuvinciuc V; Uro-Coste E; Debard A; Massip P; Delisle MB; Lassmann H; Marchou B; Mars LT; Liblau RS
    Neurology; 2013 Sep; 81(11):964-70. PubMed ID: 23935178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy: why gray and white matter.
    Gheuens S; Wüthrich C; Koralnik IJ
    Annu Rev Pathol; 2013 Jan; 8():189-215. PubMed ID: 23092189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.
    Ferenczy MW; Marshall LJ; Nelson CD; Atwood WJ; Nath A; Khalili K; Major EO
    Clin Microbiol Rev; 2012 Jul; 25(3):471-506. PubMed ID: 22763635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
    Carruthers RL; Chitnis T; Healy BC
    Mult Scler; 2014 May; 20(6):757-60. PubMed ID: 24189572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of progressive multifocal leukoencephalopathy.
    Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
    J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of progressive multifocal leukoencephalopathy.
    Berger JR; Khalili K
    Discov Med; 2011 Dec; 12(67):495-503. PubMed ID: 22204766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.
    Berger JR; Houff S
    Neurol Res; 2006 Apr; 28(3):299-305. PubMed ID: 16687057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.